Clinical trial
Effect of Growth Hormone on Bone Metabolism in Anorexia Nervosa
NCT00283595 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00283595 |
|---|---|
| Title | Effect of Growth Hormone on Bone Metabolism in Anorexia Nervosa |
| Official title | Effect of Supraphysiological rhGH on Bone Metabolism in Patients With Anorexia Nervosa |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anorexia Nervosa, Osteopenia, Osteoporosis, Eating Disorders |
| Intervention type | Drug |
| Interventions | Recombinant Human Growth Hormone, Placebo for Recombinant Human Growth Hormone |
| Enrollment | 21 |
| Start date | Jan 1, 2006 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Jan 30, 2006 |
| Last update posted | Sep 2, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: